Recurrent Gastrointestinal Bleeding in Patients With Atrial Fibrillation Treated With Left Atrial Appendage Occlusion
Pacing and Clinical Electrophysiology · 2026
DOI: 10.1111/pace.70177 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Pacing and Clinical Electrophysiology, 2026. Verfasst von Adham Ramadan und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Boston Medical Center, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Atrial Fibrillation, Gastrointestinal Hemorrhage, Left Atrial Appendage Closure, Atrial Appendage. Die Arbeit nennt 31 Literaturangaben.
Abstract (Originalsprache)
Background
Concomitant atrial fibrillation (AF) and gastrointestinal (GI) bleeding present a clinical challenge due to recurrent bleeding risk associated with anticoagulation for AF‐associated stroke prevention. Left atrial appendage occlusion (LAAO) offers an alternative stroke prevention strategy, but its impact on recurrent GI bleeding remains unknown.
Methods
This retrospective, multicenter cohort study used the TriNetX database to identify adults with AF on oral anticoagulation and a history of GI bleeding. Patients were stratified by treatment with or without LAAO. 1:1 propensity score matching (PSM) was employed. The primary outcome was recurrent GI bleeding. Cox regression analysis was used to generate hazard ratios (HRs) with 95% confidence intervals (CIs). Odds ratios (ORs) were used to evaluate effect sizes between groups. Kaplan–Meier curves were used for time‐to‐event analyses.
Results
After PSM, 9259 patients were compared in each group. Odds of recurrent GI bleeding were consistently lower in patients undergoing LAAO than without LAAO across all follow‐up intervals: at 3 months (OR 0.84; 95% CI 0.78–0.91), 6 months, 1 year, 3 years, and 5 years (OR 0.87; 95% CI 0.82–0.92). Kaplan–Meier analysis demonstrated significantly lower risk of recurrent GI bleeding with LAAO (HR 0.80; 95% CI 0.76–0.84; p < 0.01).
Conclusion
In patients with AF and prior GI bleeding, LAAO was associated with a significantly lower risk of recurrent GI bleeding at short‐term and long‐term time intervals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Boston Medical Center, Boston, Massachusetts, USA.
- Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
- Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Cardiovascular Medicine, Corewell Health William Beaumont University Hospital, Troy, Michigan, USA.
- Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
- Division of Cardiovascular Medicine, Alexandria Faculty of Medicine, Alexandria, Egypt.
ORCID-Profile: Mohamed Doma, Iuri Ferreira Felix, Ahmed K Mahmoud, Christopher V DeSimone
Zitieren
APA
Ramadan, A., Doma, M., Ferreira Felix, I., Kamel, I., Ahmed, M. S., Mahmoud, A. K., Ismayl, M., Karara, Y., Villablanca, P. A., Saw, J., DeSimone, C. V., & Goldsweig, A. M. (2026). Recurrent Gastrointestinal Bleeding in Patients With Atrial Fibrillation Treated With Left Atrial Appendage Occlusion. Pacing and Clinical Electrophysiology. https://doi.org/10.1111/pace.70177
Vancouver
Ramadan A, Doma M, Ferreira Felix I, Kamel I, Ahmed MS, Mahmoud AK, et al. Recurrent Gastrointestinal Bleeding in Patients With Atrial Fibrillation Treated With Left Atrial Appendage Occlusion. Pacing and Clinical Electrophysiology. 2026. doi:10.1111/pace.70177
BibTeX
@article{Ramadan2026,
author = {Ramadan, Adham and Doma, Mohamed and Ferreira Felix, Iuri and Kamel, Ibrahim and Ahmed, Mahmoud Samy and Mahmoud, Ahmed K and Ismayl, Mahmoud and Karara, Yehia and Villablanca, Pedro A and Saw, Jacqueline and DeSimone, Christopher V and Goldsweig, Andrew M},
title = {Recurrent Gastrointestinal Bleeding in Patients With Atrial Fibrillation Treated With Left Atrial Appendage Occlusion},
journal = {Pacing and Clinical Electrophysiology},
year = {2026},
doi = {10.1111/pace.70177}
}
EUVIMED